US Patent Issued to ASCENTAGE PHARMA (SUZHOU), REGENTS OF THE UNIVERSITY OF MICHIGAN, ASCENTAGE PHARMA GROUP on June 3 for "Macrocyclic fused pyrazoles as Mcl-1 inhibitors" (Chinese, American Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,703, issued on June 3, was assigned to ASCENTAGE PHARMA (SUZHOU) Co. LTD. (Suzhou, China), REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.) and ASCENTAGE PHARMA GROUP CORP Ltd. (Hong Kong).

"Macrocyclic fused pyrazoles as Mcl-1 inhibitors" was invented by Guozhi Tang (Suzhou, China), Dongbo Li (Suzhou, China), Liugen Li (Suzhou, China), Xianchan Zha (Suzhou, China), Wenming Chen (Suzhou, China), Shaomeng Wang (Superior Township, Mich.) and Chao-Yie Yang (Ann Arbor, Mich.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds represented by Formula IA: (IA), and the pharmaceutically acceptable salts and solvates thereof, wherein...